A naukri.com initiative
Bioengineer
13h
152
Image Credit: Bioengineer
Cell Therapy Enhances Survival Rates in Colorectal Cancer Patients
- Colorectal cancer is a significant global health challenge, with alarming mortality trends among individuals under 55.
- A study on cytokine-induced killer (CIK) cell therapy shows promising results for CRC patients, improving survival outcomes.
- CIK cells activate the immune system to target and destroy cancer cells, surpassing traditional treatments like chemotherapy.
- Patients receiving CIK therapy alongside standard treatments experienced significant improvements in progression-free and overall survival.
- Serum CEA levels were identified as predictive biomarkers for CIK therapy responsiveness in CRC patients.
- Dr. Yi Zhang highlights the potential of CIK therapy in enhancing survival and quality of life for advanced-stage CRC patients.
- Ongoing research aims to combine CIK therapy with other treatments and validate its efficacy in clinical trials.
- CIK therapy's mechanism involves enhancing immune responses and disrupting tumor growth and metastasis.
- CIK cells offer scalability and cytolytic activity, making them feasible for clinical application and potential multi-cancer therapies.
- The study's findings advocate for personalized oncology through biomarker-driven patient selection and future integration of CIK therapy in cancer treatment protocols.
Read Full Article
9 Likes
For uninterrupted reading, download the app